Category
Peptides: Growth Hormone
Every Peptides: Growth Hormone guide we have published, in one place. Evidence-based, built around what you can actually track on a GLP-1.
8 guides
CJC-1295: Mechanism, Evidence, and Regulatory Status
CJC-1295 explained: how this GHRH analog works, the DAC vs no-DAC distinction, the thin human evidence, and its non-FDA-approved status. Provider-directed only.
CJC-1295 + Ipamorelin: Why People Pair Them
The CJC-1295 plus ipamorelin stack explained: the complementary-mechanism rationale, what evidence exists, the regulatory reality, and why timing.
GH Peptides for Body Recomposition: Hype vs Evidence
Do GH peptides actually recomp your body? An honest look at growth-hormone peptides for muscle and fat, what evidence supports the claims, and what is.
Growth-Hormone Peptides Explained: GHRH vs GHRP vs Secretagogues
Growth-hormone peptides explained: how GHRH analogs, GHRPs, and oral secretagogues each raise GH, what's FDA-approved, and why category beats hype.
Ipamorelin: What It Is and What the Science Supports
Ipamorelin explained: how this selective GH secretagogue works, what limited research shows, its side-effect profile, and its non-FDA-approved status.
MK-677 (Ibutamoren): Oral GH Secretagogue, Honestly Reviewed
MK-677 (ibutamoren) explained: the oral GH secretagogue's mechanism, the human data, side effects like water retention and insulin resistance, and its legal.
Sermorelin: The Older GHRH Peptide, Explained
Sermorelin explained: the older GHRH peptide once FDA-approved, how it is used in anti-aging clinics today, its evidence base, and its current regulatory.
Tesamorelin and Visceral Fat: The One GH Peptide With FDA Approval
Tesamorelin and visceral fat: the GHRH peptide that is actually FDA-approved for HIV-related lipodystrophy, what the trials show, and how off-label interest.